Search research articles
Contact Us
Filters
Showing results (271-280 of 627) with videos related to
Page
of 63
Sort By:
American Heart Journal
|
May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial
Jeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The New England Journal of Medicine
|
June 28, 2002
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction
Ronnier J Aviles, Arman T Askari, Bertil Lindahl, et al.
Diabetologia
|
August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program
Tamara K Young, Jing-Wei Li, Amy Kang, et al.
The American Journal of Medicine
|
December 6, 2003
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes
John H Alexander, Robert A Harrington, Manju Bhapkar, et al.
Circulation. Genomic and Precision Medicine
|
April 11, 2023
Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy
Best Uchehara, Lydia Coulter Kwee, Jessica Regan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Journal of the American Heart Association
|
January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
The American Journal of Cardiology
|
January 31, 2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)
Melvin R Echols, Kenneth W Mahaffey, Anindita Banerjee, et al.
American Heart Journal
|
March 21, 2016
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry
Harsh Golwala, Larry R Jackson, DaJuanicia N Simon, et al.
Journal of the American College of Cardiology
|
February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II
B E Tardiff, R M Califf, J E Tcheng, et al.
Page
of 63
Search research articles
Search
Showing results (271-280 of 627) with videos related to
Sort By:
Page
of 63
American Heart Journal
|
May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial
Jeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The New England Journal of Medicine
|
June 28, 2002
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction
Ronnier J Aviles, Arman T Askari, Bertil Lindahl, et al.
Diabetologia
|
August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program
Tamara K Young, Jing-Wei Li, Amy Kang, et al.
The American Journal of Medicine
|
December 6, 2003
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes
John H Alexander, Robert A Harrington, Manju Bhapkar, et al.
Circulation. Genomic and Precision Medicine
|
April 11, 2023
Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy
Best Uchehara, Lydia Coulter Kwee, Jessica Regan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Journal of the American Heart Association
|
January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
The American Journal of Cardiology
|
January 31, 2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)
Melvin R Echols, Kenneth W Mahaffey, Anindita Banerjee, et al.
American Heart Journal
|
March 21, 2016
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry
Harsh Golwala, Larry R Jackson, DaJuanicia N Simon, et al.
Journal of the American College of Cardiology
|
February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II
B E Tardiff, R M Califf, J E Tcheng, et al.
Page
of 63